ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0005

The Rheumatology Access Expansion (RAE) Initiative: Improving Rheumatoid Arthritis Care on Navajo Nation Through Primary Care Provider Education

Jennifer Mandal1, Tabitha Carroway2, Zara Izadi1, Gwendolyn Grant3, Mary Margaretten2, Starla Blanks4, Nataya Cabrera4, Peter Emanuel2, Jeannie Hong5, Sheryl McCalla4, John McDougall6, Catherine Nasrallah7, McKinsey Pillsbury2 and Jinoos Yazdany2, 1University of California San Francisco, San Francisco, CA, 2UCSF, San Francisco, CA, 3Centura Health, Durango, CO, 4American College of Rheumatology, Atlanta, GA, 5Phoenix Indian Medical Center/Indian Health Service, Phoenix, AZ, 6Northern Navajo Medical Center - Shiprock, NM, Shiprock, NM, 7UCSF, San Francisco

Meeting: ACR Convergence 2022

Keywords: Access to care, education, medical, Minority Health, primary care, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 12, 2022

Title: Plenary I

Session Type: Plenary Session

Session Time: 11:30AM-1:00PM

Background/Purpose: The burden of rheumatoid arthritis (RA) in the United States falls disproportionately on communities of color and rural populations. The Navajo Nation is the largest American Indian reservation, spanning 27,000 square miles across 3 states, and is home to 250,000 tribal members. Despite the high prevalence of RA in this vulnerable population, the shortage of local rheumatology providers has shifted the provision of most RA care to primary care providers (PCPs) on the reservation. Our goal was to develop a novel RA training program for Navajo Area PCPs, and to study the impact of the program on PCPs’ knowledge and self-reported confidence in diagnosing and managing RA.

Methods: After conducting a needs assessment, we assembled an interdisciplinary team of rheumatologists, a pharmacist, and Navajo cultural interpreters to design a 12-week RA training program for PCPs, known as the Rheumatology Access Expansion (RAE) Initiative (Figure 1). We facilitated weekly interactive webinars, consisting of a didactic followed by RA case discussion. PCPs completed surveys before and after the course, with questions about their self-reported confidence in RA diagnosis and management, as well as a RA medical knowledge test. Confidence questions were grouped into 3 domains: RA diagnosis, RA management with conventional DMARDS, and management with biologics. Knowledge questions were grouped into 2 domains: RA diagnosis and RA management.  We used paired t-tests to assess changes in PCPs’ confidence and knowledge test scores, and used a linear regression model to identify confidence and knowledge domain(s) with the greatest improvements after the training program. In the post-survey, PCPs rated the usefulness of each session on a Likert scale of 1 (“not at all useful”) to 5 (“extremely useful”) and descriptive statistics (mean [SD]) were calculated.

Results: 18 PCPs participated in the program (15 physicians, 1 nurse practitioner, 1 physician associate, 1 community health worker). 10 PCPs completed pre/post-training confidence ratings, 9 completed pre/post-training knowledge tests, and 17 completed the satisfaction survey. Post-training confidence ratings were statistically significantly higher than pre-training ratings in all three domains (p< 0.05, Figure 2). Management with biologics saw the greatest improvements in confidence ratings (p for comparison with improvements in diagnosis of RA = 0.023). Performance on the knowledge test increased by 22% (95%CI: 10-34%, p=0.001). Post-training performance was significantly higher than pre-training performance in both knowledge domains (p< 0.05, Figure 3). The mean (SD) session usefulness score across all 12 sessions was 4.52 (0.77) out of 5.

Conclusion: We successfully designed and implemented the RAE Initiative, a 12-week RA training program for Navajo Nation PCPs. PCPs rated the usefulness of the curriculum highly, and pre/post survey data showed that participants improved their RA medical knowledge and confidence in the diagnosis and management of RA. This program is now offered twice a year for PCPs in the Navajo Area, and can serve as a scalable model for the development of similar programs to support other vulnerable populations disproportionately affected by RA.

Supporting image 1

Figure 1: The RAE Initiative – Program Outline

Supporting image 2

Figure 2: PCPs’ self-reported confidence in diagnosing and managing RA, pre- and post-training (N=10)

Supporting image 3

Figure 3: Mean (SD) pre-training, mean (SD) post-training, and marginal (95% CI) change in performance on RA knowledge test [N=9].

Note: Dr. Jennifer Mandal and Tabitha Carroway contributed equally to this abstract.


Disclosures: J. Mandal, None; T. Carroway, None; Z. Izadi, None; G. Grant, None; M. Margaretten, None; S. Blanks, None; N. Cabrera, None; P. Emanuel, None; J. Hong, None; S. McCalla, None; J. McDougall, None; C. Nasrallah, None; M. Pillsbury, None; J. Yazdany, AstraZeneca, Gilead, Bristol-Myers Squibb(BMS), Aurinia, Astra Zeneca, Pfizer.

To cite this abstract in AMA style:

Mandal J, Carroway T, Izadi Z, Grant G, Margaretten M, Blanks S, Cabrera N, Emanuel P, Hong J, McCalla S, McDougall J, Nasrallah C, Pillsbury M, Yazdany J. The Rheumatology Access Expansion (RAE) Initiative: Improving Rheumatoid Arthritis Care on Navajo Nation Through Primary Care Provider Education [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-rheumatology-access-expansion-rae-initiative-improving-rheumatoid-arthritis-care-on-navajo-nation-through-primary-care-provider-education/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-rheumatology-access-expansion-rae-initiative-improving-rheumatoid-arthritis-care-on-navajo-nation-through-primary-care-provider-education/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology